| Revision as of 23:52, 19 September 2020 edit98.117.49.212 (talk) →Hyperthyroidism: new section← Previous edit | Revision as of 13:50, 20 October 2021 edit undoOxinabox (talk | contribs)240 edits Add comment about US-Centric Anxiety sectionTag: RevertedNext edit → | ||
| Line 22: | Line 22: | ||
| I left the line about abrupt withdrawal possibly causing a thyroid storm because that is in the propanolol document (and added the citation that wasn't there), but it doesn't contraindicate the use of beta blockers to treat hyperthyroidism and shouldn't be in that section. I'm just not sure how to fit it into the Adverse Effects section smoothly. I'm also not sure if it should even be included in the article, since I assume hyperthyroidism is not the only condition for which suddenly stopping beta blockers can be potentially dangerous, but it's the only disorder for which it's mentioned. (And if we're being pedantic, that citation is only for propanolol and not for other beta blockers.) | I left the line about abrupt withdrawal possibly causing a thyroid storm because that is in the propanolol document (and added the citation that wasn't there), but it doesn't contraindicate the use of beta blockers to treat hyperthyroidism and shouldn't be in that section. I'm just not sure how to fit it into the Adverse Effects section smoothly. I'm also not sure if it should even be included in the article, since I assume hyperthyroidism is not the only condition for which suddenly stopping beta blockers can be potentially dangerous, but it's the only disorder for which it's mentioned. (And if we're being pedantic, that citation is only for propanolol and not for other beta blockers.) | ||
| == Anxiety section US-Centric == | |||
| Right now the Anxiety section starts with "Officially, beta blockers are not approved for anxiolytic use by the U.S. Food and Drug Administration." | |||
| and doesn't have much more content than that. | |||
| However, in many other countries, e.g. , , they are occasionally used for this. | |||
| At present, I don't have time to format that into a update to that paragraph. | |||
| ] (]) 13:50, 20 October 2021 (UTC) | |||
Revision as of 13:50, 20 October 2021
This article was the subject of a Wiki Education Foundation-supported course assignment, between 23 July 2019 and 30 August 2019. Further details are available on the course page. Student editor(s): DJay29, Realcoolchick, Amriya, Inocanreadbrah, Isoniazid (article contribs).
 | Ideal sources for Misplaced Pages's health content are defined in the guideline Misplaced Pages:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Beta blocker.
|
| This is the talk page for discussing improvements to the Beta blocker article. This is not a forum for general discussion of the article's subject. |
|
| Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL |
Archives: 1Auto-archiving period: 2 months  |
 | Pharmacology C‑class Top‑importance | |||||||||
| ||||||||||
 | The Wikimedia Foundation's Terms of Use require that editors disclose their "employer, client, and affiliation" with respect to any paid contribution; see WP:PAID. For advice about reviewing paid contributions, see WP:COIRESPONSE.
|
.
Hyperthyroidism
I removed hyperthyroidism from the list of contraindications because the source doesn't list it as a contraindication for beta blockers; it says that it can exacerbate hyperthyroid symptoms if discontinued abruptly. Hyperthyroidism is also listed as an indication for beta blockers earlier in the article, so it's contradicting itself.
I also removed the sentence claiming that beta blockers should be used with caution because "tachycardia is a useful monitoring parameter in thyroid disease" because it was uncited and I doubt it's possible to find a citation for this. I'm not sure what kind of doctor would be ok with not treating a patient's abnormally high heart rate because it's a (not very precise) indicator that their thyroid levels are abnormal.
I left the line about abrupt withdrawal possibly causing a thyroid storm because that is in the propanolol document (and added the citation that wasn't there), but it doesn't contraindicate the use of beta blockers to treat hyperthyroidism and shouldn't be in that section. I'm just not sure how to fit it into the Adverse Effects section smoothly. I'm also not sure if it should even be included in the article, since I assume hyperthyroidism is not the only condition for which suddenly stopping beta blockers can be potentially dangerous, but it's the only disorder for which it's mentioned. (And if we're being pedantic, that citation is only for propanolol and not for other beta blockers.)
Anxiety section US-Centric
Right now the Anxiety section starts with "Officially, beta blockers are not approved for anxiolytic use by the U.S. Food and Drug Administration." and doesn't have much more content than that. However, in many other countries, e.g. UK, Australia, they are occasionally used for this. At present, I don't have time to format that into a update to that paragraph. Oxinabox (talk) 13:50, 20 October 2021 (UTC)
Categories: